Combo Tx 'Right Direction' for Advanced Endometrial Cancer

]]>(MedPage Today) -- Lenvatinib (Lenvima) plus pembrolizumab (Keytruda) showed "compelling efficacy" for advanced endometrial carcinoma, regardless of tumor microsatellite instability (MSI) status, findings from an international phase Ib/II trial...